CN117858715A - 一种烧烫伤药酊及其制备方法 - Google Patents
一种烧烫伤药酊及其制备方法 Download PDFInfo
- Publication number
- CN117858715A CN117858715A CN202380011119.6A CN202380011119A CN117858715A CN 117858715 A CN117858715 A CN 117858715A CN 202380011119 A CN202380011119 A CN 202380011119A CN 117858715 A CN117858715 A CN 117858715A
- Authority
- CN
- China
- Prior art keywords
- parts
- tincture
- scalds
- burns
- ethanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 77
- 229940098465 tincture Drugs 0.000 title claims abstract description 63
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000003814 drug Substances 0.000 claims abstract description 63
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 56
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 14
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 14
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 14
- 239000004863 Frankincense Substances 0.000 claims abstract description 14
- 240000007311 Commiphora myrrha Species 0.000 claims abstract description 13
- 235000006965 Commiphora myrrha Nutrition 0.000 claims abstract description 13
- 235000007265 Myrrhis odorata Nutrition 0.000 claims abstract description 13
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 11
- 244000080767 Areca catechu Species 0.000 claims abstract description 11
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 11
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 11
- 241001071917 Lithospermum Species 0.000 claims abstract description 11
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims abstract description 10
- 235000003097 Artemisia absinthium Nutrition 0.000 claims abstract description 10
- 240000001851 Artemisia dracunculus Species 0.000 claims abstract description 10
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims abstract description 10
- 235000003717 Boswellia sacra Nutrition 0.000 claims abstract description 10
- 235000012035 Boswellia serrata Nutrition 0.000 claims abstract description 10
- 241000972673 Phellodendron amurense Species 0.000 claims abstract description 10
- 239000001138 artemisia absinthium Substances 0.000 claims abstract description 10
- 229940116229 borneol Drugs 0.000 claims abstract description 10
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 10
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 10
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 8
- 241000050051 Chelone glabra Species 0.000 claims abstract 4
- 229940079593 drug Drugs 0.000 claims description 16
- 238000002791 soaking Methods 0.000 claims description 12
- 241000037740 Coptis chinensis Species 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 238000001035 drying Methods 0.000 claims description 9
- 239000000243 solution Substances 0.000 claims description 9
- 241000219061 Rheum Species 0.000 claims description 7
- 238000000227 grinding Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 240000004980 Rheum officinale Species 0.000 claims description 5
- 235000008081 Rheum officinale Nutrition 0.000 claims description 5
- 241000717739 Boswellia sacra Species 0.000 claims description 4
- 230000003203 everyday effect Effects 0.000 claims description 4
- 238000002386 leaching Methods 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 238000007873 sieving Methods 0.000 claims description 4
- 244000235603 Acacia catechu Species 0.000 claims description 3
- 241000628997 Flos Species 0.000 claims description 3
- 241001057584 Myrrha Species 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000011521 glass Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims description 3
- 239000008227 sterile water for injection Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 239000000706 filtrate Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 29
- 230000008901 benefit Effects 0.000 abstract description 5
- 241000411851 herbal medicine Species 0.000 abstract description 5
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract description 2
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 244000299790 Rheum rhabarbarum Species 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 21
- 230000036407 pain Effects 0.000 description 20
- 231100000241 scar Toxicity 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 18
- 208000027418 Wounds and injury Diseases 0.000 description 16
- 230000035876 healing Effects 0.000 description 14
- 208000004210 Pressure Ulcer Diseases 0.000 description 13
- 206010052428 Wound Diseases 0.000 description 11
- 208000015181 infectious disease Diseases 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 230000019612 pigmentation Effects 0.000 description 10
- 230000008961 swelling Effects 0.000 description 10
- 208000032544 Cicatrix Diseases 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 7
- 241000207929 Scutellaria Species 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 230000006378 damage Effects 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 230000001717 pathogenic effect Effects 0.000 description 7
- 230000037387 scars Effects 0.000 description 7
- 239000003053 toxin Substances 0.000 description 7
- 231100000765 toxin Toxicity 0.000 description 7
- 206010011985 Decubitus ulcer Diseases 0.000 description 6
- 235000019658 bitter taste Nutrition 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 206010007247 Carbuncle Diseases 0.000 description 5
- 206010039509 Scab Diseases 0.000 description 5
- 238000005469 granulation Methods 0.000 description 5
- 230000003179 granulation Effects 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000010926 purge Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 208000003656 Electric Burns Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 208000012260 Accidental injury Diseases 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 231100000517 death Toxicity 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010061623 Adverse drug reaction Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 241000123844 Artemisia anomala Species 0.000 description 1
- 235000014290 Artemisia anomala Nutrition 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000218202 Coptis Species 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 206010063560 Excessive granulation tissue Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010018291 Gingival swelling Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 206010033078 Otitis media Diseases 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 240000001745 Rheum palmatum Species 0.000 description 1
- 235000008090 Rheum palmatum Nutrition 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- WNFXUXZJJKTDOZ-HNNXBMFYSA-N [(1s)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] acetate Chemical compound C1=CC(O)=C2C(=O)C([C@@H](OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-HNNXBMFYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 208000012876 acute enteritis Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- -1 anthraquinone compounds Chemical class 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 210000000613 ear canal Anatomy 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001126 granulation tissue Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000019633 pungent taste Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- WNFXUXZJJKTDOZ-UHFFFAOYSA-N shikonin acetate Natural products C1=CC(O)=C2C(=O)C(C(OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-UHFFFAOYSA-N 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
- 210000000707 wrist Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种烧烫伤药酊及其制备方法,包括如下组分:金银花、刘寄奴、紫草、黄连、大黄、黄柏、黄芩、儿茶、乳香、没药、冰片、80%的乙醇;具有中草药酒精气味,选合适的纯天然中药材及其配比,各组分之间相互配合,协同作用,在制备方法上力求简便易操作,最大限度保持药物新鲜,绿色环保,制备方法操作简单,疗效显著,用药方便,副作用小,成本低廉,经济实惠。
Description
技术领域
本发明涉及中药技术领域,具体是指一种烧烫伤药酊及其制备方法。
背景技术
烧伤主要指热力、化学物质、电能、放射线等引起的皮肤、粘膜,甚至深部组织的损害。其中皮肤热力烧伤(如火焰、开水等)最为多见。据统计,每年因意外伤害的死亡人数,烧伤仅次于交通事故,排在第二位,而且在交通事故伤害中也有大量伤员合并烧伤。
烧伤的严重程度取决于受伤组织的范围和深度,烧伤深度可分为Ⅰ度、Ⅱ度和Ⅲ度。Ⅰ度烧伤损伤最轻,烧伤皮肤发红、疼痛、明显触痛、有渗出或水肿,轻压受伤部位时局部变白,但没有水疱。Ⅱ度烧伤损伤较深,皮肤水疱,水疱底部呈红色或白色,充满了清澈、粘稠的液体,触痛敏感,压迫时变白。Ⅲ度烧伤损伤最深,烧伤表面发白、变软或者呈黑色、炭化皮革状,由于被烧皮肤变得苍白,在白皮肤人中常被误认为正常皮肤,但压迫时不再变色,破坏的红细胞可使烧伤局部皮肤呈鲜红色,偶尔有水疱,烧伤区的毛发很容易拔出,感觉减退。Ⅲ度烧伤区域因皮肤的神经末梢被破坏一般没有痛觉,烧伤后常常要经过几天才能区分深Ⅱ度与Ⅲ度烧伤。
烫伤是日常生活中常见的疾患,主要是由沸水、沸油、摩托车排气管、太阳紫外线等接触人体表面,而导致局部皮肤、组织损伤,造成人体功能障碍、疼痛、局部坏死等一系列临床症状,常伴潮红水肿,表面大量液体渗出,以伤处红肿灼痛、起泡、结焦痂为主要表现症状。烫伤轻者损及皮毛,甚则伤及肌肉筋内,严重者,火毒炽盛,伤津耗液,邪毒侵入营血,内攻脏腑而生诸症。临床上根据烫伤程度,将其分三度:Ⅰ度烫伤:烫伤只损伤皮肤表层,局部轻度红肿、无水泡、疼痛明显;Ⅱ度烫伤:烫伤是真皮损伤,局部红肿疼痛,有大小不等的水泡;Ⅲ度烫伤是皮下,脂肪、肌肉、骨骼都有损伤,并呈灰或红褐色。对大面积烫伤,宜尽早送医院治疗。
中医学认为,烧烫伤是由于火热毒邪侵袭机体,导致肌表受损,脉络不通,热盛肉腐,肌表不全,津液淋沥,机体阴液亏损,可出现局部红肿、水泡、疮疡等临床症状,故外用药以清热解毒、活血化瘀、收敛止痛为主。
烧烫伤治疗中存在创面疼痛、进行性坏死、易感染、瘢痕愈合四大难题,因此,迫切需要寻找更为有效的治疗药物。日常生活中,常会发生因行动不慎引起的皮肤烧伤或烫伤,轻者疼痛发红、重者起泡甚至表皮剥脱坏死,伤至骨头。如不及时医治,病邪和细菌侵入,不仅会扩大创面,皮肤溃烂,甚至造成感染,产生败血症,导致死亡。采用西药治疗烧烫伤虽然具有见效快、疗效确切的优点,但西药对人体有一定的刺激性,并且在一定程度上能产生耐药性和副作用。现有技术中也有一些治疗烧烫伤的中药组合物,但是这些组合物都存在下述问题,即见效慢,疗程长,效果差,不能自然愈合,甚至感染化脓,易留疤痕。所以,一种烧烫伤药酊及其制备方法成为人们亟待解决的问题。
发明内容
本发明要解决的技术问题是提供一种通过选择合适的纯天然中药材及其配比,制备出一种无刺激,无毒副作用,患者易接受,安全度高,见效快,治疗烧烫伤效果好,能快速消除烧烫伤引起的疼痛、红肿等并发症,并防止烧烫伤面扩大、感染化脓,促使烧烫伤面快速愈合,不留疤痕的治疗烧烫伤的中药酊剂及其制备方法
为解决上述技术问题,本发明提供的技术方案为一种烧烫伤药酊,包括如下重量份的组分:金银花100-500份、刘寄奴150-450份、紫草150-500份、黄连200-400份、大黄250-700份、黄柏600-1000份、黄芩500-900份、儿茶200-700份、乳香250-650份、没药300-700份、冰片300-800份、80%的乙醇5000-15000ml。
作为改进,包括如下重量份的组分:金银花200-400份、刘寄奴200-300份、紫草150-300份、黄连300-400份、大黄400-600份、黄柏700-900份、黄芩700-900份、儿茶400-600份、乳香300-600份、没药400-550份、冰片400-700份、80%的乙醇8000-12000ml ml。
作为改进,包括如下重量份的组分:金银花300份、刘寄奴300份、紫草300份、黄连300份、大黄500份、黄柏800份、黄芩800份、儿茶500份、乳香500份、没药500份、冰片500份、80%的乙醇10000ml。
一种烧烫伤药酊的制备方法,包括如下步骤:
1)按照组分的重量份比称取各组分;
2)将金银花、紫草、刘寄奴、黄连、黄芩、黄柏、大黄、乳香及没药经干燥后,按比例混合、粉粹、研磨呈粗粉,儿茶经干燥后,研磨呈细粉;
3)将研磨后的药物浸泡于80%的乙醇中密封7-10日;
4)收集渗滤液药渣再加入80%的乙醇浸渍5-7日后渗滤压渣;
5)收集滤液二次合并加入冰片和注射用水浸泡溶解;
6)采用40目过滤分装于密闭之棕色玻璃瓶内或小喷雾器内备用即可得本发明治疗烧烫伤的药酊。
作为改进,所述步骤2中药物研磨后粗粉过50目筛,细粉过100目筛。
作为改进,所述步骤5中溶解过程中需测用酒精计检查浸出液的乙醇含量,再加灭菌注射用水稀释成72%-75%之间。
作为改进,所述步骤3中,浸泡过程中每日振摇或搅拌1次。
本发明配方所采用的各种药材的来源及功能主治如下:
以下三药为主要:
金银花属半常绿缠绕藤本植物,味甘性寒,用于痈肿疔疮,喉痹,丹毒,热毒血痢,风热感冒,温病发热。含绿原酸,肌醇等。具有清热解毒之功效,杀菌抗微生物作用,对绿脓杆菌、溶血性链球菌、金黄色葡萄球菌等多种致病菌有杀菌、抑菌作用。
刘寄奴菊科蒿属植物,味苦性温,具有活血祛瘀,通经止疼,凉血止血,清热利湿之功效;
紫草味甘性寒,具有清热凉血,活血解毒,透疹消斑之功效,紫草含有乙酰紫草素,能使发炎创面的毛细血管降低通透性、减少体液渗出,并使坏死的皮肤形成致密的蛋白质,促进上皮组织迅速生长愈合,不留疤痕。
以下四药为臣药:
黄连为毛茛科、黄连属多年生草本植物。味苦,具有清热燥湿泻火解毒之功效;用于湿热痞满,呕吐吞酸,泻痢,黄疸,高热神昏,心火亢盛,心烦不寐,血热吐衄,目赤,牙痛,消渴,痈肿疔疮;外治湿疹,湿疮,耳道流脓。酒黄连善清上焦火热,用于目赤,口疮。现代药理研究证明黄连具广谱抗菌性,尤其对金黄色葡萄球菌、溶血性链球菌敏感。
黄芩为唇形科黄芩属植物;味苦性寒。具有清热泻火,燥湿解毒止血之功效;主治温热病、上呼吸道感染、肺热咳嗽、湿热黄胆、肺炎、痢疾、咳血、目赤、胎动不安、高血压、痈肿疖疮等症。
黄柏为芸香科、黄檗属植物黄皮树或黄檗的干燥树皮;味苦性寒,具有清热燥湿,泻火解毒,收敛止痒之功效。主治急性细菌性痢疾、急性肠炎、急性黄疸型肝炎、泌尿系统感染等炎症。外用治火烫伤、中耳炎、急性结膜炎等。
大黄为蓼科植物掌叶大黄、唐古特大黄或药用大黄的干燥根和根茎,味苦性寒,具有清热泻火凉血解毒,泻下攻积,活血祛瘀之功效。四味配合,加强清热解毒,收敛燥湿的功效,有助于缓解血热引起的吐血、衄血、咯血、咽喉肿痛、牙龈肿痛、目赤肿痛等症状,大黄中含有的蒽醌类化合物可以促进血小板生成,缩短凝血时间,有利于止血,具有很强的抗感染、止痛作用,对多种革兰氏阳性和阴性细菌有抑制作用,尤其对葡萄球菌和链球菌敏感。
以下二药为佐药,二药常相配合,能增强其消肿止痛,活血祛瘀:
乳香为橄榄科植物乳香树及同属植物树皮渗出的树脂,味辛苦性温,具有消肿定痛,消肿生肌之功效。用于胸痹心痛,胃脘疼痛,痛经经闭,产后瘀阻,症瘕腹痛,风湿痹痛,筋脉拘挛,跌打损伤,痈肿疮疡。
没药为橄榄科植物地丁树或哈地丁树的干燥树脂,味辛苦平,具有消肿生肌,活血祛瘀止痛之功效,主治跌打损伤,金疮,筋骨,心腹诸痛,症瘕,经闭,痈疽肿痛,疮疡溃后久不收口。
以下二药为使药:
儿茶为豆科植物,性寒,味苦,具有活血止痛,止血生肌,收湿敛疮之功效。属止血药下属分类的化瘀止血药。
冰片为龙脑香科植物龙脑香的树脂和挥发油加工品提取获得的结晶;气味辛苦,微寒,具有止疼防腐,清热生肌之功效。能增加肉芽组织结构和表皮细胞再生,修复皮肤附属器官而具促进创伤愈合作用。
在本方中,用80%乙醇作为溶剂,能把药物的有效成分,通过浸泡充分溶解提取。在临床上最常用的医用乙醇是75%的,通常使用于表皮消毒,因为过高度数的乙醇会给细菌的表面形成保护膜,阻止杀入细菌的体内难以彻底杀菌。如果浓度过低,虽然可以进入细菌体内,但是不能彻底将体内的蛋白质进行凝固,所以用72%--75%的浓度乙醇,是最有消毒杀菌的作用,并且能促进皮肤伤处血液循环。协助上药消毒杀菌作用。
全方相辅相成,配伍严谨,用药得当,故能凑效。
本发明与现有技术相比的优点在于:
1)本发明治疗烧烫伤药酊具有中草药酒精气味,是根据祖传秘方,选合适的纯天然中药材及其配比,各组分之间相互配合,协同作用,在制备方法上力求简便易操作,最大限度保持药物新鲜,尽量采用生药,药物炒用、蒸用都不如生用,外治用药,生用疗效最好;
2)本发明治疗烧烫伤药酊无刺激,无毒副作用,患者易接受,安全度高,见效快,治疗烧烫伤效果好,能快速消除烧烫伤引起的疼痛、红肿等并发症,并防止烧烫伤面扩大、感染化脓,促使烧烫伤面快速愈合;
3)本发明主治各种体表烫伤、皮肤溃疡、脓包疮、祷疮、伤口感染、脚气感染等,本发明治疗烧烫伤药酊成本低、效果好,是一种适合于广谱性医用和家庭用治疗烧烫伤的药剂,同时本发明提供的治疗烧烫伤药酊制备、使用及携带方便,对烧烫伤病症治疗效果显著。
具体实施方式
下面将对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅是本发明的一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。
实施例1,本发明治疗烧烫伤药酊,包括如下重量克的组分:金银花100克、刘寄奴150克、紫草150克、黄连200克、大黄250克、黄柏600克、黄芩500克、儿茶200克、乳香250克、没药300克、冰片300克、80%的乙醇5000ml。
实施例2,本发明治疗烧烫伤药酊,包括如下重量克的组分:金银花500克、刘寄奴450克、紫草500克、黄连400克、大黄700克、黄柏1000克、黄芩900克、儿茶700克、乳香650克、没药700克、冰片800克、80%的乙醇12000ml。
实施例3,金银花300克、刘寄奴300克、紫草300克、黄连300克、大黄500克、黄柏800克、黄芩800克、儿茶500克、乳香500克、没药500克、冰片500克、80%的乙醇10000ml。
本发明治疗烧烫伤药酊的制备方法,包括如下步骤:
1)按照组分的重量份比称取各组分;
2)将金银花、紫草、刘寄奴、黄连、黄芩、黄柏、大黄、乳香及没药经干燥后,按比例混合、粉粹、研磨呈粗粉过50目筛,儿茶经干燥后,研磨呈细粉过100目筛;
3)将研磨后的药物浸泡于80%的乙醇7000毫升中密封10日,每日振摇或搅拌1次,7至10日后,收集渗漉液;
4)药渣再加80%乙醇3000ml浸渍7日,浸渍完毕,压榨取尽,所得2次漉液合井;
5)再将冰片加入浸泡中使溶解;
6)用酒精计检查浸出液的乙醇含量,再加灭菌注射用水稀释成72%-75%之间,静置,用40目过滤分装于密闭之棕色玻璃瓶内或小喷雾器内备用。
本发明治疗烧烫伤药酊使用方法为:使用时用小喷雾器将药酊喷涂于患者伤处的相应部位。
产品性状
本品为棕色或棕褐色的半透明液体,具有醇和冰片的特殊气味。
功能与主治
具有抗菌、消炎、活血生肌,收敛止痛的功能。主要用于各种浅深度和各种面积的烧烫伤创面。可用于皮肤病性各种溃疡、脓疱疮、褥疮(压疮)。外伤口感染及脚气感染等。
用法
先将烧烫伤创面用0.1%新洁尔溶液或其他消毒水清洗,去除污染物,剪除部分大的水泡及脱落的痂片,吸干水分。用喷雾器或棉球将烧伤药酊布满伤面。伤面应完全暴露,重者每小时喷药1至2次.伤面形成干涸的药痂后可改为2~4小时喷洒一次。
注意:①用此药不能包扎创面,采用暴露疗法直至愈合;②用药期间伤面不能受压;③因系乙醇在开始用药时特别是浅II度烧烫伤用药时疼痛明显,但持续时间10S左右,一般较能耐受,如果面积较大喷药前可服少量镇痛剂及表面麻醉剂。④受伤部位要抬高;⑤愈合阶段有奇痒,应防止撕抓;形成的结痂千万不要做清除处理,应自行脱落直至痊愈。(6)本品没药有效期,久置产生沉淀时,不影响治疗效果。
典型病例:
王金月,女,17岁。面部,颈部,胸部烫伤Ⅰ度,占体表面积6%左右;用本发明中药烧烫伤酊治疗,每日喷涂6次,连用一周左右,共用本发明烧烫伤酊剂100毫升3瓶半,一周后痊愈,伤处无疤痕无色素沉着。
李金芝,女,45岁。腿部烫伤Ⅱ度,体表占面积3%左右,用本发明中药烧烫伤酊剂治疗,每日喷涂6次,连用一周左右,共用本发明烧烫伤酊剂100毫升2瓶半,一周后痊愈,伤处没留疤痕。
肖卫东,男,29岁。头部,颈部,背部烫伤Ⅱ度,占体表面积29%;用本发明烧烫伤酊治疗,每2小时喷涂一次,连用2周左右,共用本发明烧烫伤酊用100毫升10瓶。2周后痊愈。伤处没有留疤痕和色素沉着。依照片为证。手机号码;15589006976.。
华德栋,男,27岁。右侧高压电烧伤,1,右足电烧伤0.3%Ⅲ度,,足底部可见电流穿出口。2,右上肢及肩背部电烧伤1%,深2度。3,左上下肢电烧伤,占体表面积1%深Ⅱ度。除了用西药治疗外,用本发明烧烫伤酊100毫升5瓶,2周后大部分伤处痊愈,还有右足底部电流穿出口处未完全愈合,继续治疗一周后痊愈,愈后未留疤痕无色素沉着。依病例及照片为证。手机号码:15216514998.
张建美,女,47岁。脚面部撵压伤。在医院住院2个月未愈出院。脚面伤处无皮肤,时常流脓水1年多,不能走路,形成慢性溃疡。用本发明中药烧烫伤酊治疗,每日喷涂四次,连用一年半左右。共用2500毫升。基本痊愈。依照片为证。手机号码15853954780
马丽丽,女,6岁。左手臂Ⅰ度烫伤。占体表面积2%左右。用本发明中药烧烫伤药酊喷涂5次,连用1周痊愈共用本发明烧烫伤酊100毫升1瓶半。愈后伤口不留疤痕,无色素沉着。
郭景福,男,56岁。右下肢腿部烫伤Ⅱ度。占体表面积3%左右。用本发明烧烫伤酊治疗,每日喷涂6次。12天痊愈。共用本发明烧烫伤酊100毫升3瓶,愈后患处不留疤痕和色素沉着。
巩祥财,男,53岁。左大腿前面外面烫伤Ⅱ度。占体表面积5,5%左右。用本发明烧烫伤药酊治疗,每日喷涂6—8次,2周左右痊愈。共用烧烫伤药酊100毫升5瓶。愈后不留疤痕和色素沉着。
王晓丹,女,6岁。双大腿部,臀部烫伤Ⅱ度。占体表面积7%左右。用本发明烧烫伤药酊治疗,嚗露疗法,每日外表面喷涂6-8次。2周左右痊愈。共用本发明烧烫伤药酊100毫升6瓶。愈后没留疤痕和色素沉着。
麻娟,女,5岁。右手腕部,手面部烫伤Ⅰ度。占体表面积4%左右。用本发明烧烫伤药酊治疗,每日喷涂6次。连用一周,共用本发明中药烧烫伤酊剂100毫升3瓶,一周后痊愈,伤口无疤痕无色素沉着。
刘洪静,女,49岁。左下肢腿部烫伤Ⅱ度。占体表面积4%左右。用本发明中药烧烫伤药酊剂治疗。每日6—8次,连用2周左右,共用中药酊剂100毫升4瓶,2周后痊愈,伤处没有留下疤痕,无色素沉着。
患褥疮感染用烧烫伤药治疗典型病例
病例一,高利英,女,94岁。因长期卧床,患褥疮感染(压疮),占体表面积3%,先用抗感染药物治疗,效果不佳。用本发明中药烧烫伤酊剂,每日喷涂6次,二周后患处痊愈,共用中药酊剂100毫升3瓶,没有留下疤痕。
病例二,华明启,男,67岁,脑出血后植物人,患褥疮(压疮)感染。用本发明中药酊剂喷涂治疗,每日6次,一周后患处痊愈,共用中药酊剂100毫升3瓶,没有留下疤痕。
病例三,密景花,女,86岁。半身不遂多年,患褥疮(压疮)感染,用本发明中药酊剂喷涂治疗,每日6次,一周后患处痊愈,共用中药酊剂100毫升2瓶,没有留下疤痕。
病例四,华守理,男,89岁。半半身不遂多年。患褥疮(压疮)感染,用本发明中药酊剂喷涂治疗,每日6次,一周后患处痊愈,共用中药酊剂100毫升2瓶,没有留下疤痕。
病例五,林传俊,男,76岁。脑梗死植物人,患褥疮(压疮)感染,用本发明中药酊酊喷涂治疗每日6次,一周后患处痊愈。共用本发明中药酊剂100毫升2瓶没有留下疤痕。
病例六,张宗礼,男85岁。脑出血植物人,患褥疮(压疮)感染,用本发明中药酊剂喷涂治疗,每日5次,10天后患处痊愈。共用中药酊剂100毫升3瓶,没有留下疤痕,但皮肤有白色颜色沉着。
需说明的是:产品乙醇含量应为72%~75%,浸出液半澄明,少量沉淀,其他应符合中国药典酊剂项下之规定。
以上组成中的中药原料,可以用适当的具有相同药性的中药替换,替换后的中药制剂其药物作用不变。
以上组方中,药的重量是以生药计算的,以重量份作为配比,在生产时可按照比例增大或减小,如大规模生产可以以公斤或吨为单位,小规模生产时可以以克或毫克为单位,重量可以增大或减小,但各组成之间的生药材重量配比的比例不变。
在此有必要指出的是,以上实施例和试验例仅限于对本发明的技术方案做进一步的阐述和理解,不能理解为对本发明的技术方案做进一步的限定,本领域技术人员作出的非突出实质性特征和显著进步的发明创造,仍然属于本发明的保护范畴。
Claims (7)
1.一种烧烫伤药酊,其特征在于,包括如下重量份的组分:金银花100-500份、刘寄奴150-450份、紫草150-500份、黄连200-400份、大黄250-700份、黄柏600-1000份、黄芩500-900份、儿茶200-700份、乳香250-650份、没药300-700份、冰片300-800份、80%的乙醇5000-15000ml。
2.根据权利要求1所述的一种烧烫伤药酊,包括如下重量份的组分:金银花200-400份、刘寄奴200-300份、紫草150-300份、黄连300-400份、大黄400-600份、黄柏700-900份、黄芩700-900份、儿茶400-600份、乳香300-600份、没药400-550份、冰片400-700份、80%的乙醇8000-12000ml。
3.根据权利要求2所述的一种烧烫伤药酊,其特征在于:金银花300份、刘寄奴300份、紫草300份、黄连300份、大黄500份、黄柏800份、黄芩800份、儿茶500份、乳香500份、没药500份、冰片500份、80%的乙醇10000ml。
4.一种烧烫伤药酊的制备方法,其特征在于,包括如下步骤:
1)按照组分的重量份比称取各组分;
2)将金银花、紫草、刘寄奴、黄连、黄芩、黄柏、大黄、乳香及没药经干燥后,按比例混合、粉粹、研磨呈粗粉,儿茶经干燥后,研磨呈细粉;
3)将研磨后的药物浸泡于80%的乙醇中密封7-10日;
4)收集渗滤液药渣再加入80%的乙醇浸渍5-7日后渗滤压渣;
5)收集滤液二次合并加入冰片和注射用水浸泡溶解;
6)采用40目过滤分装于密闭之棕色玻璃瓶内或小喷雾器内备用即可得本发明治疗烧烫伤的药酊。
5.根据权利要求4所述的一种烧烫伤药酊的制备方法,其特征在于:所述步骤2中药物研磨后粗粉过50目筛,细粉过100目筛。
6.根据权利要求4所述的一种烧烫伤药酊的制备方法,其特征在于:所述步骤5中溶解过程中需测用酒精计检查浸出液的乙醇含量,再加灭菌注射用水稀释成72%-75%之间。
7.根据权利要求4所述的一种烧烫伤药酊的制备方法,其特征在于:所述步骤3中,浸泡过程中每日振摇或搅拌1次。
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2023121615 | 2023-09-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117858715A true CN117858715A (zh) | 2024-04-09 |
Family
ID=90534690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202380011119.6A Pending CN117858715A (zh) | 2023-09-26 | 2023-09-26 | 一种烧烫伤药酊及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117858715A (zh) |
-
2023
- 2023-09-26 CN CN202380011119.6A patent/CN117858715A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11571452B2 (en) | Method of treating a skin wound with a liquid-state topical pharmaceutical composition | |
CN103055052A (zh) | 一种治疗烧伤、烫伤的膏剂及其制备方法 | |
CN102988555A (zh) | 烧烫伤润肤膏 | |
CN104645122A (zh) | 一种治疗热毒浸淫型褥疮的药物及其制备方法 | |
CN102106920B (zh) | 一种治疗烧烫伤的中药组合物及其用途 | |
CN117858715A (zh) | 一种烧烫伤药酊及其制备方法 | |
CN103142727B (zh) | 治疗人体烧烫伤的中草药组合物 | |
CN108721442B (zh) | 治疗烧烫伤及尿布皮炎的中药组合物、制剂及其制备方法 | |
CN101690753B (zh) | 治疗烧伤的中药制剂及其制备方法 | |
CN113813308A (zh) | 一种治疗烧烫伤的药物及其制备方法 | |
CN108066466A (zh) | 一种治疗烧烫伤的中药组合物及其制备方法与应用 | |
CN108567868A (zh) | 一种护肤溃愈外用中药组合物及其制备方法 | |
CN116570700B (zh) | 一种具有抑菌、消炎、祛痘功效的中药制剂及其应用 | |
CN106109854A (zh) | 一种促进皮肤伤口愈合的药物组合物 | |
CN100438890C (zh) | 一种组织缺损原位再生膏剂 | |
CN100352469C (zh) | 一种治疗烧烫伤的外用药物 | |
CN101721578A (zh) | 一种治疗烧烫伤的中药去腐生肌膏 | |
CN106511676A (zh) | 一种临床护理上用于治疗褥疮的中药组合物 | |
CN107397918B (zh) | 一种治疗瘙痒的外用药物及其制备方法 | |
CN114099421A (zh) | 一种治疗烫、烧伤的外用中药制剂及其制备方法 | |
CN104491104A (zh) | 一种临床护理上用于治疗褥疮的中药组合物 | |
CN117045745A (zh) | 一种治疗肛裂的中药组合物 | |
CN114028480A (zh) | 一种治疗溃疡的纯中药浓缩膏剂及其制备方法 | |
CN113521158A (zh) | 一种治疗创面溃烂、疮疡外伤及皮肤病的外用药 | |
CN116139215A (zh) | 一种外用抗感染的中药洗剂的中药组合物、制备方法及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |